Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
N. Engl. J. Med 2021 Apr 10;[EPub Ahead of Print], GK Friedman, JM Johnston, AK Bag, JD Bernstock, R Li, I Aban, K Kachurak, L Nan, KD Kang, S Totsch, C Schlappi, AM Martin, D Pastakia, R McNall-Knapp, S Farouk Sait, Y Khakoo, MA Karajannis, K Woodling, JD Palmer, DS Osorio, J Leonard, MS Abdelbaki, A Madan-Swain, TP Atkinson, RJ Whitley, JB Fiveash, JM Markert, GY GillespieFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.